347 related articles for article (PubMed ID: 31685792)
1. Effect of dapagliflozin on obstructive sleep apnea in patients with type 2 diabetes: a preliminary study.
Tang Y; Sun Q; Bai XY; Zhou YF; Zhou QL; Zhang M
Nutr Diabetes; 2019 Nov; 9(1):32. PubMed ID: 31685792
[TBL] [Abstract][Full Text] [Related]
2. Clinical efficacy and metabolomics study of Wendan Decoction in the treatment of phlegm-dampness obstructive sleep apnea-hypopnea syndrome with type 2 diabetes mellitus.
Zhou S; Xu H; Zhu J; Fan X; Zhang J
J Ethnopharmacol; 2023 Dec; 317():116775. PubMed ID: 37311503
[TBL] [Abstract][Full Text] [Related]
3. [Short-term intensive combined therapy with metformin, sagliptin and dapagliflozin for newly diagnosed type 2 diabetes: efficacy, weight control and safety].
Xu Y; Wu P; Wen W; Chen H
Nan Fang Yi Ke Da Xue Xue Bao; 2019 Nov; 39(11):1305-1311. PubMed ID: 31852646
[TBL] [Abstract][Full Text] [Related]
4. Empagliflozin versus dapagliflozin in patients with type 2 diabetes inadequately controlled with metformin, glimepiride and dipeptidyl peptide 4 inhibitors: A 52-week prospective observational study.
Ku EJ; Lee DH; Jeon HJ; Oh TK
Diabetes Res Clin Pract; 2019 May; 151():65-73. PubMed ID: 30954510
[TBL] [Abstract][Full Text] [Related]
5. Effect of Dapagliflozin on Glycemic Control, Weight, and Blood Pressure in Patients with Type 2 Diabetes Attending a Specialist Endocrinology Practice in Canada: A Retrospective Cohort Analysis.
Brown RE; Gupta N; Aronson R
Diabetes Technol Ther; 2017 Nov; 19(11):685-691. PubMed ID: 28829163
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of dapagliflozin plus saxagliptin vs monotherapy as added to metformin in patients with type 2 diabetes: A meta-analysis.
Zhuang Y; Song J; Ying M; Li M
Medicine (Baltimore); 2020 Jul; 99(30):e21409. PubMed ID: 32791755
[TBL] [Abstract][Full Text] [Related]
7. [Effect of CPAP therapy on dynamic glucose level in OSAHS patients with newly diagnosed T2DM].
Zhao L; Hui P; Xie Y; Hou Y; Wei X; Ma W; Wang J; Zhou L; Zhang W
Zhonghua Yi Xue Za Zhi; 2015 Nov; 95(44):3579-83. PubMed ID: 26813368
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of dapagliflozin in Asian patients with type 2 diabetes after metformin failure: A randomized controlled trial.
Yang W; Han P; Min KW; Wang B; Mansfield T; T'Joen C; Iqbal N; Johnsson E; Ptaszynska A
J Diabetes; 2016 Nov; 8(6):796-808. PubMed ID: 26589253
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of triple therapy with dapagliflozin add-on to dual therapy over 52 weeks in patients with uncontrolled type 2 diabetes mellitus in a centre of high complexity, Cali-Colombia.
Joaqui VB; Gómez NB; Ortiz RC; Toro LMO; Lombo JPM; Cifuentes CAS; García MAM; Lomba AA
Arch Endocrinol Metab; 2021 Nov; 65(1):49-59. PubMed ID: 33444492
[TBL] [Abstract][Full Text] [Related]
10. Effects of Dapagliflozin and Sitagliptin on Insulin Resistant and Body Fat Distribution in Newly Diagnosed Type 2 Diabetic Patients.
Sun Y; Yan D; Hao Z; Cui L; Li G
Med Sci Monit; 2020 Apr; 26():e921891. PubMed ID: 32240122
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of dapagliflozin on vascular endothelial function and glycemic control in patients with early-stage type 2 diabetes mellitus: DEFENCE study.
Shigiyama F; Kumashiro N; Miyagi M; Ikehara K; Kanda E; Uchino H; Hirose T
Cardiovasc Diabetol; 2017 Jul; 16(1):84. PubMed ID: 28683796
[TBL] [Abstract][Full Text] [Related]
12. Durability of glycaemic efficacy over 2 years with dapagliflozin versus glipizide as add-on therapies in patients whose type 2 diabetes mellitus is inadequately controlled with metformin.
Nauck MA; Del Prato S; Durán-García S; Rohwedder K; Langkilde AM; Sugg J; Parikh SJ
Diabetes Obes Metab; 2014 Nov; 16(11):1111-20. PubMed ID: 24919526
[TBL] [Abstract][Full Text] [Related]
13. The SGLT2 Inhibitor Dapagliflozin Significantly Improves the Peripheral Microvascular Endothelial Function in Patients with Uncontrolled Type 2 Diabetes Mellitus.
Sugiyama S; Jinnouchi H; Kurinami N; Hieshima K; Yoshida A; Jinnouchi K; Nishimura H; Suzuki T; Miyamoto F; Kajiwara K; Jinnouchi T
Intern Med; 2018 Aug; 57(15):2147-2156. PubMed ID: 29607968
[TBL] [Abstract][Full Text] [Related]
14. Dapagliflozin in patients with type II diabetes mellitus, with and without elevated triglyceride and reduced high-density lipoprotein cholesterol levels.
Bays HE; Sartipy P; Xu J; Sjöström CD; Underberg JA
J Clin Lipidol; 2017; 11(2):450-458.e1. PubMed ID: 28502502
[TBL] [Abstract][Full Text] [Related]
15. The association between the phenotype of excessive daytime sleepiness and blood pressure in patients with obstructive sleep apnea-hypopnea syndrome.
Wang Q; Zhang C; Jia P; Zhang J; Feng L; Wei S; Luo Y; Su L; Zhao C; Dong H; Ma J; Wang G
Int J Med Sci; 2014; 11(7):713-20. PubMed ID: 24843321
[TBL] [Abstract][Full Text] [Related]
16. Randomized, Double-Blind, Phase 3 Trial of Triple Therapy With Dapagliflozin Add-on to Saxagliptin Plus Metformin in Type 2 Diabetes.
Mathieu C; Ranetti AE; Li D; Ekholm E; Cook W; Hirshberg B; Chen H; Hansen L; Iqbal N
Diabetes Care; 2015 Nov; 38(11):2009-17. PubMed ID: 26246458
[TBL] [Abstract][Full Text] [Related]
17. COMBINED TREATMENT WITH SAXAGLIPTIN PLUS DAPAGLIFLOZIN REDUCES INSULIN LEVELS BY INCREASED INSULIN CLEARANCE AND IMPROVES β-CELL FUNCTION.
Ekholm E; Hansen L; Johnsson E; Iqbal N; Carlsson B; Chen H; Hirshberg B
Endocr Pract; 2017 Mar; 23(3):258-265. PubMed ID: 27849380
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and Renal Safety of Dapagliflozin in Patients with Type 2 Diabetes Mellitus Also Receiving Metformin: A Real-Life Experience.
Scorsone A; Saura G; Fleres M; Spano L; Aiello V; Brancato D; Di Noto A; Provenzano F; Provenzano V
J Diabetes Res; 2018; 2018():8501418. PubMed ID: 29854825
[TBL] [Abstract][Full Text] [Related]
19. Dapagliflozin has no effect on markers of bone formation and resorption or bone mineral density in patients with inadequately controlled type 2 diabetes mellitus on metformin.
Ljunggren Ö; Bolinder J; Johansson L; Wilding J; Langkilde AM; Sjöström CD; Sugg J; Parikh S
Diabetes Obes Metab; 2012 Nov; 14(11):990-9. PubMed ID: 22651373
[TBL] [Abstract][Full Text] [Related]
20. A retrospective real-world study of dapagliflozin versus other oral antidiabetic drugs added to metformin in patients with type 2 diabetes.
Huang H; Bell KF; Gani R; Tugwell CW; Eudicone JM; Krukas-Hampel MR
Am J Manag Care; 2018 Apr; 24(8 Suppl):S132-S137. PubMed ID: 29693359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
